Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Vasomotor Symptom Associated With Menopause”

14 trials

Showing 14 of 14 results

Testing effectiveness (Phase 2)Study completedNCT03596762
What this trial is testing

BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms

Who this might be right for
MenopauseHot FlashesNight Waking
Bayer 199
Large-scale testing (Phase 3)Study completedNCT00535288
What this trial is testing

Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)

Who this might be right for
Postmenopausal SymptomsMenopauseVasomotor Symptoms
Merck Sharp & Dohme LLC 946
Large-scale testing (Phase 3)Study completedNCT00560833
What this trial is testing

Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)

Who this might be right for
MenopauseVasomotor Symptoms
Merck Sharp & Dohme LLC 943
Not applicableEnded earlyNCT01353963
What this trial is testing

Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients

Who this might be right for
Major Depressive DisorderVasomotor Symptoms
Pfizer 13
Not applicableStudy completedNCT02792504
What this trial is testing

Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive

Who this might be right for
Severe Vasomotor Symptom Associated With Menopause
Pfizer 669
Post-approval studies (Phase 4)Study completedNCT02195609
What this trial is testing

Evaluate the Effect of Omega-3 vs Soy Isoflavones in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Who this might be right for
MenopauseHot Flashes
Instituto Palacios 75
Large-scale testing (Phase 3)Study completedNCT04003142
What this trial is testing

Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2

Who this might be right for
Hot Flashes
Astellas Pharma Global Development, Inc. 501
Testing effectiveness (Phase 2)Study completedNCT05325775
What this trial is testing

Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause

Who this might be right for
Post-menopausal Vasomotor Symptoms
Acer Therapeutics Inc. 49
Large-scale testing (Phase 3)Study completedNCT04003155
What this trial is testing

Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma Global Development, Inc. 527
Testing effectiveness (Phase 2)Study completedNCT06812754
What this trial is testing

Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma Global Development, Inc. 150
Large-scale testing (Phase 3)Study completedNCT04234204
What this trial is testing

Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma China, Inc. 302
Not applicableStudy completedNCT04553029
What this trial is testing

A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS)

Who this might be right for
Menopause
Astellas Pharma Singapore Pte. Ltd. 3,399
Large-scale testing (Phase 3)Study completedNCT00238732
What this trial is testing

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

Who this might be right for
Vaginal Atrophy
Wyeth is now a wholly owned subsidiary of Pfizer 650
Testing effectiveness (Phase 2)Looking for participantsNCT07118891
What this trial is testing

Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause

Who this might be right for
Vasomotor Symptoms Associated With MenopauseHealthy Volunteers
AbCellera Biologics Inc. 136

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation